264 related articles for article (PubMed ID: 19884519)
1. Cardiovascular disease with androgen deprivation: the (forgotten) role of testosterone.
Aragon-Ching JB
J Clin Oncol; 2009 Dec; 27(35):e261; author reply e262. PubMed ID: 19884519
[No Abstract] [Full Text] [Related]
2. Competing risks for patients with localized prostate cancer.
Seidenfeld J; Samson DJ; Albertsen PC
J Natl Cancer Inst; 2007 Oct; 99(20):1498-9. PubMed ID: 17925533
[No Abstract] [Full Text] [Related]
3. Abiraterone and MVD3100 take androgen deprivation to a new level.
Schmidt C
J Natl Cancer Inst; 2011 Feb; 103(3):175-6. PubMed ID: 21242338
[No Abstract] [Full Text] [Related]
4. Researchers probe consequences of androgen deprivation for prostate cancer.
Friedrich MJ
JAMA; 2006 Nov; 296(19):2305-6. PubMed ID: 17105787
[No Abstract] [Full Text] [Related]
5. Does the benefit justify the risk?
Albertsen PC
J Natl Cancer Inst; 2010 Jan; 102(1):4-5. PubMed ID: 19996059
[No Abstract] [Full Text] [Related]
6. [Castration of prostate cancer patients and cognition].
Portin R; Koskinen A; Helenius H; Nurmi M; Salminen E
Duodecim; 2005; 121(16):1784-5. PubMed ID: 16268226
[No Abstract] [Full Text] [Related]
7. Cardiovascular toxicity of androgen deprivation therapy: a new door opens.
Alibhai SM
J Clin Oncol; 2011 Sep; 29(26):3500-2. PubMed ID: 21844507
[No Abstract] [Full Text] [Related]
8. Pathologic effects of testosterone deprivation.
Sprenkle PC; Fisch H
Curr Opin Urol; 2007 Nov; 17(6):424-30. PubMed ID: 17921778
[TBL] [Abstract][Full Text] [Related]
9. Metabolic changes in patients with prostate cancer during androgen deprivation therapy.
Mitsuzuka K; Arai Y
Int J Urol; 2018 Jan; 25(1):45-53. PubMed ID: 29052905
[TBL] [Abstract][Full Text] [Related]
10. Cardiovascular risk during androgen deprivation therapy for prostate cancer.
Jones TH
BMJ; 2011 May; 342():d3105. PubMed ID: 21610041
[No Abstract] [Full Text] [Related]
11. Bisphosphonates effective in preventing bone complications associated with androgen deprivation therapy.
J Support Oncol; 2006 Feb; 4(2):99-100. PubMed ID: 16499137
[No Abstract] [Full Text] [Related]
12. Watchful waiting beats androgen deprivation therapy in early prostate cancer.
Brower V
J Natl Cancer Inst; 2008 Nov; 100(21):1494-6. PubMed ID: 18957680
[No Abstract] [Full Text] [Related]
13. Metabolic and cardiovascular effects of androgen deprivation therapy.
Hakimian P; Blute M; Kashanian J; Chan S; Silver D; Shabsigh R
BJU Int; 2008 Dec; 102(11):1509-14. PubMed ID: 18727614
[TBL] [Abstract][Full Text] [Related]
14. The role of intermittent androgen deprivation in prostate cancer.
Boccon-Gibod L; Hammerer P; Madersbacher S; Mottet N; Prayer-Galetti T; Tunn U
BJU Int; 2007 Oct; 100(4):738-43. PubMed ID: 17662079
[No Abstract] [Full Text] [Related]
15. Androgen deprivation therapy, insulin resistance, and cardiovascular mortality: an inconvenient truth.
Basaria S
J Androl; 2008; 29(5):534-9. PubMed ID: 18567642
[TBL] [Abstract][Full Text] [Related]
16. Management of side effects of androgen deprivation therapy.
Grossmann M; Zajac JD
Endocrinol Metab Clin North Am; 2011 Sep; 40(3):655-71, x. PubMed ID: 21889727
[TBL] [Abstract][Full Text] [Related]
17. Re: does comorbidity influence the risk of myocardial infarction or diabetes during androgen-deprivation therapy for prostate cancer?
Griebling TL
J Urol; 2014 Jun; 191(6):1784-5. PubMed ID: 25280283
[No Abstract] [Full Text] [Related]
18. I'm on androgen deprivation therapy (ADT) for prostate cancer. I've heard that it may cause heart problems. Should I be worried?
Johns Hopkins Med Lett Health After 50; 2010 May; 22(3):8. PubMed ID: 20518140
[No Abstract] [Full Text] [Related]
19. More should be done to prevent the harmful effects of long-term androgen ablation therapy in prostate cancer.
Barrass BJ; Thurairaja R; Persad RA
BJU Int; 2004 Jun; 93(9):1175-6. PubMed ID: 15180599
[No Abstract] [Full Text] [Related]
20. Cardiovascular risk profile of veteran men beginning androgen deprivation therapy.
Williams L; Hicks E; Kwan L; Litwin M; Maliski S
J Vasc Nurs; 2014 Sep; 32(3):99-104. PubMed ID: 25131756
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
